top of page
LISTEN TO THE POD
EMAIL SUBSCRIBE
WATCH ON THE PEN
🏠 HOME
📰 GLP-1 NEWS
📺 LIVE SHOW
🌕 ABOUT
OTP BOOK
More
Use tab to navigate through the menu items.
Log In
Quintuple Agonist for Obesity: One Drug, 5 Receptors
HUGE! Employers Can Now Offer Zepbound Through New Lilly Program!
Update: CMS and Eli Lilly Release New Details on Medicare GLP-1 Coverage Pilot
HUGE! Employers Can Now Offer Zepbound Through New Lilly Program!
MASSIVE Winter Storm Could Spoil Your GLP-1 Meds
OTP EXLCUSIVE: Mounjaro and Zepbound MULTI-USE Vials Coming Soon!
ZEPBOUND + TALTZ Improves Psoriatic Arthritis Symptoms in Phase 3b Trial!
BREAKING: Zepbound Savings Card 2026 What We Know, Don’t Know, and Why the Silence Is Its Own Story
Zepbound Self Pay Prices Drop Across All Doses Effective Today
Exclusive: FDA Adds Hair Loss to Zepbound’s Side Effects
OTP EXCLUSIVE: What the New FDA Breastfeeding Study Means for Moms on Zepbound and Mounjaro
False and Misleading: What the FDA Says About Zepbound, Mounjaro, Wegovy
The Week Obesity Medicine Shook: Generics, MASH, CV Claims, and Lilly’s Exit
AS SEEN IN
bottom of page
.png)
